当前位置:首页 - 行情中心 - 兴齐眼药(300573) - 财务分析 - 现金流量表

兴齐眼药

(300573)

  

流通市值:151.16亿  总市值:196.79亿
流通股本:1.88亿   总股本:2.45亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,833,095,200.261,140,671,875.59531,751,958.341,879,008,345.8
  收到其他与经营活动有关的现金15,040,435.5215,100,925.1113,293,678.2819,698,104.21
  经营活动现金流入小计1,848,135,635.781,155,772,800.7545,045,636.621,898,706,450.01
  购买商品、接受劳务支付的现金140,630,297.0689,201,779.4328,549,744.93146,862,617.13
  支付给职工以及为职工支付的现金467,601,331.97305,850,969.36163,577,708.14558,026,438.19
  支付的各项税费241,149,021.54166,090,711.8968,370,912.72215,147,348.73
  支付其他与经营活动有关的现金424,234,800.91289,079,458.4493,925,340.95561,687,082.78
  经营活动现金流出小计1,273,615,451.48850,222,919.12354,423,706.741,481,723,486.83
  经营活动产生的现金流量净额574,520,184.3305,549,881.58190,621,929.88416,982,963.18
二、投资活动产生的现金流量:
  处置固定资产、无形资产和其他长期资产收回的现金净额44,247.7944,247.79-326,000
  投资活动现金流入的平衡项目00-0
  投资活动现金流入小计44,247.7944,247.79-326,000
  购建固定资产、无形资产和其他长期资产支付的现金131,875,957.5688,822,269.8733,351,433.77198,710,063.3
  投资支付的现金---10,000,000
  支付其他与投资活动有关的现金---7,284,068.52
  投资活动现金流出小计131,875,957.5688,822,269.8733,351,433.77215,994,131.82
  投资活动产生的现金流量净额-131,831,709.77-88,778,022.08-33,351,433.77-215,668,131.82
三、筹资活动产生的现金流量:
  吸收投资收到的现金---22,167,470.64
  取得借款收到的现金181,000,000150,000,00080,000,000310,000,000
  收到其他与筹资活动有关的现金28,763,009.8128,743,814.18909,197.64,867,351.75
  筹资活动现金流入小计209,763,009.81178,743,814.1880,909,197.6337,034,822.39
  偿还债务支付的现金261,000,000180,000,000100,000,000180,000,000
  分配股利、利润或偿付利息支付的现金350,904,435.8178,095,818.761,518,937.2466,573,730.15
  支付其他与筹资活动有关的现金29,508,575.2626,617,003.361,545,213.829,247,386.47
  筹资活动现金流出小计641,413,011.06384,712,822.12103,064,151.02655,821,116.62
  筹资活动产生的现金流量净额-431,650,001.25-205,969,007.94-22,154,953.42-318,786,294.23
四、汇率变动对现金及现金等价物的影响-1,647,447.59-1,624,291.66-78,921.6-109,296.21
五、现金及现金等价物净增加额9,391,025.699,178,559.9135,036,621.09-117,580,759.08
  加:期初现金及现金等价物余额362,837,182.96362,837,182.96362,837,182.96480,417,942.04
  期末现金及现金等价物余额372,228,208.65372,015,742.86497,873,804.05362,837,182.96
补充资料:
  净利润-334,826,054.8-338,061,776.59
  资产减值准备-8,790,633.82-8,036,272.7
  固定资产和投资性房地产折旧-41,930,834.96-84,413,365.38
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-41,930,834.96-84,413,365.38
  无形资产摊销-5,355,829.66-9,586,503.23
  长期待摊费用摊销-1,320,827.91-4,000,638.05
  处置固定资产、无形资产和其他长期资产的损失--74,796.81-978,359.46
  固定资产报废损失---14,050,574.47
  财务费用-4,427,696.75-5,822,076.18
  递延所得税-474,376.36-1,841,875.6
  其中:递延所得税资产减少-474,376.36-1,841,875.6
  存货的减少--30,519,985.24--20,990,416.43
  经营性应收项目的减少--74,486,798.66--144,415,694.62
  经营性应付项目的增加-4,586,582.83-95,544,245.63
  其他-4,198,975.22-11,551,965.9
  现金的期末余额-372,015,742.86-362,837,182.96
  减:现金的期初余额-362,837,182.96-480,417,942.04
  现金及现金等价物的净增加额-9,178,559.9--117,580,759.08
公告日期2025-10-292025-08-282025-04-292025-04-22
审计意见(境内)标准无保留意见
TOP↑